IBEX
IBEX Limited
IBEX's outlook is improving, though it still trails on the overall score.
PLTR
Palantir Technologies Inc.
PLTR has the edge over IBEX overall, supported by stronger valuation and stronger modeled upside.
IBEX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
IBEX's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
PLTR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
PLTR's revenue, profitability, cash flow and balance sheet are all currently strong.
IBEX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $33.48 | -39% |
| Fair | 13x | $42.92 | -22% |
| Forward | 14x | $54.87 | — |
| Current | 17x | $54.87 | — |
| Expensive | 20x | $66.14 | +21% |
Historical ranges are pointers, not guarantees.
IBEX's PE is in its expensive range at 17x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its fair range.
PLTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 75x | $172 | — |
| Current | 120x | $172 | — |
| Cheap | 165x | $236 | +37% |
| Fair | 251x | $359 | +109% |
| Expensive | 452x | $646 | +277% |
Historical ranges are pointers, not guarantees.
PLTR has the edge over IBEX in the historical PE scenario, which offers more potential upside but is not a forecast.
IBEX Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for IBEX, with profitability holding steady.
PLTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
PLTR has the edge over IBEX on the outlook, with more favorable profitability expectations.
IBEX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.95 | +20% |
| Q3 2026 | $3.30 | +20% |
| Q2 2026 | $3.13 | +33% |
| Q1 2026 | $3.17 | +39% |
| Q4 2025 | $3.01 | +42% |
| Q3 2025 | $2.75 | +46% |
| Q2 2025 | $2.36 | +28% |
| Q1 2025 | $2.28 | +49% |
| Q4 2024 | $2.12 | +35% |
IBEX's earnings per share have climbed steadily: $3.30 over the past year, up 20% from the year before, and higher year over year for 17 quarters in a row.
PLTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.30 | +61% |
| Q3 2026 | $1.43 | +240% |
| Q2 2026 | $1.17 | +290% |
| Q1 2026 | $0.89 | +287% |
| Q4 2025 | $0.63 | +232% |
| Q3 2025 | $0.42 | +110% |
| Q2 2025 | $0.30 | +76% |
| Q1 2025 | $0.23 | +92% |
| Q4 2024 | $0.19 | +111% |
PLTR has the edge over IBEX on earnings, with stronger typical year-over-year growth.
IBEX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $175.2M | +16% |
| Q2 2026 | $164.3M | +12% |
| Q1 2026 | $164.4M | +17% |
| Q4 2025 | $164.2M | +17% |
| Q3 2025 | $151.2M | +17% |
| Q2 2025 | $147.1M | +18% |
| Q1 2025 | $140.7M | +11% |
| Q4 2024 | $140.7M | +6.1% |
IBEX's revenue has grown year over year for 10 quarters in a row: $175M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | +1.4 points |
| Q2 2026 | 6% | -2.3 points |
| Q1 2026 | 9.8% | +0.4 points |
| Q4 2025 | 9.3% | +0.8 points |
| Q3 2025 | 9.1% | +2.1 points |
| Q2 2025 | 8.3% | -2 points |
| Q1 2025 | 9.5% | +0.6 points |
| Q4 2024 | 8.5% | +3.2 points |
IBEX's operating margin was 10% last quarter, up 1.4 points from the same quarter a year ago, near the top of its range since 2019.
PLTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.3B | +96% |
| Q2 2026 | $1.9B | +93% |
| Q1 2026 | $1.6B | +85% |
| Q4 2025 | $1.4B | +70% |
| Q3 2025 | $1.2B | +63% |
| Q2 2025 | $1B | +48% |
| Q1 2025 | $883.9M | +39% |
| Q4 2024 | $827.5M | +36% |
PLTR has the edge over IBEX on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +14 points |
| Q2 2026 | 47% | +20 points |
| Q1 2026 | 46% | +26 points |
| Q4 2025 | 41% | +40 points |
| Q3 2025 | 33% | +18 points |
| Q2 2025 | 27% | +11 points |
| Q1 2025 | 20% | +7.2 points |
| Q4 2024 | 1.3% | -9.5 points |
PLTR has the edge over IBEX on profitability, with a higher operating margin.
IBEX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9.2M | +14% |
| Q2 2026 | $21.7M | -4.9% |
| Q1 2026 | $6.6M | +85% |
| Q4 2025 | -$5.1M | -$1.9M |
| Q3 2025 | $8M | +94% |
| Q2 2025 | $22.8M | +50% |
| Q1 2025 | $3.6M | -63% |
| Q4 2024 | -$3.2M | +$1.4M |
IBEX still generates free cash flow, though less than at its 2022 peak: $32M over the past year.
PLTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +139% |
| Q2 2026 | $1.2B | +126% |
| Q1 2026 | $891.8M | +193% |
| Q4 2025 | $764M | +67% |
| Q3 2025 | $500.9M | +20% |
| Q2 2025 | $531.6M | +276% |
| Q1 2025 | $304.1M | +140% |
| Q4 2024 | $457.2M | +54% |
PLTR has the edge over IBEX on cash flow, with more consistent year-over-year improvement.
IBEX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.3% | +187K shares |
| 1 year | +2.6% | +386K shares |
| 3 years | -21% | -3.9M shares |
| 5 years | -21% | -3.9M shares |
| Available history | -15% | -2.7M shares |
IBEX has 15M diluted shares, up 2.6% from a year ago, despite $16M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.5M |
| Q2 2026 | $4.2M |
| Q1 2026 | $4.6M |
| Q4 2025 | $2.8M |
| Q3 2025 | $2.8M |
| Q2 2025 | $1.6M |
| Q1 2025 | $25.1M |
| Q4 2024 | $46.6M |
IBEX spent $16M buying back its own shares over the past year, down 79% from the year before.
PLTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +5.2M shares |
| 1 year | +0.1% | +2.9M shares |
| 3 years | +11% | +248M shares |
| 5 years | +31% | +610M shares |
| Available history | +184% | +1.7B shares |
PLTR has the edge over IBEX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $19.2M |
| Q3 2025 | $19.2M |
| Q2 2025 | $18.6M |
| Q1 2025 | $18M |
| Q4 2024 | $18.6M |
| Q3 2024 | $18.9M |
| Q2 2024 | $17.7M |
| Q1 2024 | $9M |
IBEX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.4x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | -0.2x | Net Cash |
IBEX has more cash than debt.
PLTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.9x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q1 2025 | -2.3x | Net Cash |
| Q4 2024 | -6.1x | Net Cash |
PLTR has the edge over IBEX on leverage, with a lower net debt burden relative to earnings.
IBEX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 78.3 | Overbought |
| Stochastic | 91.0 | Overbought |
IBEX's weekly RSI is 78 (overbought) and its Stochastic is 91 (overbought).
PLTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 47.4 | Neutral |
PLTR's weekly RSI is 51 (neutral) and its Stochastic is 47 (neutral).
IBEX PE vs Technology Sector
| Metric | IBEX | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 28x | 40% below |
| PE % | 73 | 37 | 36 pts above |
IBEX has the edge over PLTR on valuation relative to its sector.
PLTR PE vs Technology Sector
| Metric | PLTR | Sector median | Relative |
|---|---|---|---|
| PE | 120x | 28x | 331% above |
| PE % | 1 | 38 | 37 pts below |
PLTR is trading at 120x earnings, a 331% premium to the Technology sector's median of 28x.
IBEX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $46.8 | 17% above |
| 20 week MA | $40.6 | 35% above |
| 50 week MA | $35.5 | 54% above |
| 100 week MA | $32.3 | 70% above |
| 200 week MA | $25.5 | 115% above |
IBEX has the edge over PLTR on trend strength, trading above more of its moving averages.
PLTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $185.8 | 7.6% below |
| 20 week MA | $167.6 | 2.4% above |
| 50 week MA | $157.1 | 9.2% above |
| 100 week MA | $143.8 | 19% above |
| 200 week MA | $83.3 | 106% above |
PLTR's trend is up, with a small recent dip: it's below only its 8-week average, and 106% above its 200-week average.
IBEX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.4 | $20.1 | +30% |
| 2021 | $20.1 | $13.9 | -31% |
| 2022 | $13.9 | $25.6 | +84% |
| 2023 | $25.6 | $19.0 | -26% |
| 2024 | $19.0 | $21.4 | +13% |
| 2025 | $21.4 | $38.5 | +80% |
| 2026 YTD | $38.5 | $54.9 | +43% |
IBEX has the edge over PLTR on returns for 2026, with the stronger performance.
PLTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.20 | $27.8 | +202% |
| 2021 | $27.8 | $18.9 | -32% |
| 2022 | $18.9 | $6.29 | -67% |
| 2023 | $6.29 | $17.2 | +173% |
| 2024 | $17.2 | $79.1 | +361% |
| 2025 | $79.1 | $188.7 | +139% |
| 2026 YTD | $188.7 | $171.6 | -9.1% |
PLTR's yearly returns have swung widely, from +361% in 2024 to −67% in 2022. It's down 9.1% so far in 2026.